Skip to main content
. 2024 Apr 26;15:3557. doi: 10.1038/s41467-024-47399-x

Table 1.

Independent association signals uncovered at known CRC risk loci in conditional analyses (conditional P < 1 × 10−6)

Fine-mapping region SNP Chr Position Nearby gene Alleles AF Single-SNP analysis Joint analysis Group
OR (95% CI) P valuea OR (95% CI) P valueb
region_1 rs11579545 1 22249333 HSPG2 T/C 0.445 0.96 (0.95–0.98) 4.34E−07 0.96 (0.95–0.98) 5.63E−07 Trans-ancestry
region_1 rs112191583 1 22554378 MIR4418 T/C 0.974 0.88 (0.83–0.92) 1.19E−07 0.87 (0.83–0.92) 5.29E−08 Trans-ancestry
region_1 rs12137525 1 22584118 MIR4418 T/C 0.107 1.07 (1.04–1.09) 2.90E−08 1.08 (1.06–1.11) 1.14E−11 European
region_9 rs12122827 1 202172769 LGR6 T/G 0.715 1.04 (1.02–1.06) 9.44E−07 1.05 (1.03–1.06) 7.94E−08 European
region_22 rs2554878 3 41200064 RP11-372H2.1 T/G 0.036 1.12 (1.08–1.16) 5.85E−09 1.12 (1.08–1.16) 3.75E−09 Trans-ancestry
region_27 rs9283588 3 133874566 RYK A/G 0.715 1.06 (1.04–1.07) 3.43E−10 1.04 (1.03–1.06) 7.32E−07 Trans-ancestry
region_30 rs902443 4 105888417 RP11-556I14.1 A/T 0.536 1.04 (1.03–1.06) 1.49E−11 1.04 (1.03–1.06) 1.26E−11 Trans-ancestry
region_36 rs582489 5 39908712 GCSHP1 T/C 0.570 0.97 (0.96–0.99) 8.23E−05 0.96 (0.94–0.97) 7.29E−09 European
region_36 rs77781678 5 40626064 SNORA63 T/C 0.020 0.84 (0.79–0.89) 2.09E−09 0.84 (0.79–0.89) 1.75E−09 European
region_43 rs4714081 6 11977905 RP11-456H18.1 A/G 0.451 0.96 (0.95–0.97) 2.50E−09 0.96 (0.95–0.97) 1.21E−09 Trans-ancestry
region_43 rs4714350 6 12270290 EDN1 A/T 0.283 0.96 (0.94–0.97) 8.60E−09 0.96 (0.95–0.98) 4.43E−07 Trans-ancestry
region_43 rs17615624 6 12376025 RN7SKP293 C/G 0.975 0.87 (0.83–0.91) 7.29E−09 0.88 (0.84–0.92) 2.28E−07 European
region_44 rs3094576 6 29516242 OR2I1P A/C 0.131 0.94 (0.92–0.96) 1.83E−07 0.94 (0.92–0.96) 2.26E−08 European
region_44 rs2517671 6 29937977 MICD A/G 0.591 0.96 (0.95–0.98) 2.35E−08 0.96 (0.95–0.97) 2.87E−09 Trans-ancestry
region_45 rs6920820 6 30969938 MUC22 C/G 0.980 0.84 (0.79–0.9) 6.87E−08 0.8 (0.75–0.85) 1.89E−12 European
region_45 rs9264180 6 31219902 HLA-C A/C 0.570 1.03 (1.02–1.05) 1.71E−06 1.04 (1.02–1.05) 5.62E−07 Trans-ancestry
region_45 rs9265501 6 31297568 XXbac-BPG248L24.10 A/G 0.678 0.88 (0.85–0.92) 3.05E−10 0.88 (0.84–0.91) 5.21E−11 European
region_45 rs116000952 6 32541270 HLA-DRB1 T/G 0.843 0.92 (0.89–0.96) 5.74E−06 0.9 (0.87–0.94) 1.50E−08 European
region_45 rs2858331 6 32681277 XXbac-BPG254F23.7 A/G 0.601 1.03 (1.02–1.05) 1.18E−05 1.05 (1.04–1.07) 2.67E−13 Trans-ancestry
region_50 rs13204733 6 55566108 RP11-228O6.2 A/G 0.858 0.94 (0.92–0.96) 4.20E−08 0.93 (0.91–0.95) 1.17E−12 European
region_60 rs10089517 8 60178721 SNORA51 A/C 0.380 1.03 (1.02–1.05) 7.44E−07 1.03 (1.02–1.05) 2.81E−07 Trans-ancestry
region_61 rs117310502 8 117593052 EIF3H A/G 0.048 0.92 (0.89–0.96) 9.36E−05 0.88 (0.85–0.92) 4.03E−10 European
region_61 rs72681666 8 117641754 EIF3H T/C 0.043 1.09 (1.05–1.13) 1.57E−05 1.12 (1.08–1.17) 6.99E−10 European
region_61 rs1793717 8 118278575 SNORA31 A/C 0.629 1.03 (1.02–1.05) 6.90E−05 1.04 (1.03–1.06) 1.55E−07 European
region_62 rs79122086 8 128397907 CASC8 T/G 0.840 0.92 (0.9–0.93) 5.46E−20 0.94 (0.93–0.96) 9.34E−10 Trans-ancestry
region_62 rs77569096 8 128468955 CASC8 A/G 0.763 0.92 (0.9–0.94) 2.06E−15 0.93 (0.91–0.95) 2.67E−12 European
region_68 rs4994332 9 137117194 RP11-145E17.2 T/C 0.423 0.97 (0.96–0.98) 4.05E−05 0.96 (0.95–0.97) 9.08E−08 European
region_74 rs117746067 10 101222300 RP11-441O15.3 A/G 0.101 1.06 (1.03–1.08) 3.64E−06 1.08 (1.05–1.1) 1.74E−09 European
region_80 rs9795065 11 74376844 POLD3 T/C 0.981 1.19 (1.13–1.25) 5.37E−13 1.17 (1.12–1.23) 6.06E−11 Trans-ancestry
region_85 rs1003563 12 6424577 PLEKHG6 A/G 0.433 0.95 (0.94–0.97) 1.67E−12 0.95 (0.94–0.96) 1.23E−14 Trans-ancestry
region_106 rs68097734 14 92717447 RP11-472N19.3 T/C 0.496 1.06 (1.03–1.09) 7.71E−06 NA Asian
region_108 rs28630996 15 32993860 SCG5 A/T 0.713 0.9 (0.89–0.92) 1.25E−32 0.93 (0.91–0.94) 3.02E−17 Trans-ancestry
region_108 rs144674978 15 33149751 FMN1 T/C 0.013 1.34 (1.25–1.43) 1.11E−18 1.23 (1.15–1.31) 3.82E−10 European
region_109 rs3784710 15 68072458 MAP2K5 T/C 0.763 1.05 (1.03–1.07) 1.32E−07 1.05 (1.03–1.07) 1.34E−08 European
region_111 rs12913420 15 90797010 RP11-697E2.6 C/G 0.376 1.04 (1.03–1.06) 2.29E−09 NA Trans-ancestry
region_114 rs11117455 16 86179919 RP11-805I24.4 T/C 0.181 1.04 (1.02–1.06) 7.52E−06 1.05 (1.03–1.07) 6.97E−07 European
region_115 rs73975588 17 816741 NXN A/C 0.874 1.09 (1.07–1.12) 6.62E−16 1.07 (1.04–1.09) 6.08E−09 European
region_117 rs112592783 17 70633625 LINC00511 T/C 0.175 1.05 (1.03–1.07) 5.87E−09 1.05 (1.03–1.07) 5.95E−09 Trans-ancestry
region_120 rs4939821 18 46371993 CTIF T/C 0.304 0.91 (0.89–0.92) 4.12E−32 0.96 (0.94–0.97) 1.89E−07 European
region_121 rs72971616 19 987366 WDR18 T/G 0.063 0.92 (0.89–0.95) 4.89E−06 NA European
region_126 rs12460535 19 49098750 SULT2B1 A/G 0.349 0.96 (0.95–0.98) 5.76E−07 NA European
region_127 rs8099852 19 58895221 RPS5 T/C 0.546 1.03 (1.02–1.05) 5.15E−07 NA Trans-ancestry
region_133 rs1971480 20 48897080 RP11-290F20.3 T/G 0.672 0.96 (0.95–0.98) 8.61E−07 0.96 (0.94–0.97) 6.50E−09 European
region_133 rs149942633 20 48983073 RP11-290F20.2 T/C 0.153 1.12 (1.08–1.16) 1.93E−08 1.1 (1.05–1.14) 3.94E−06 European
region_133 rs6126008 20 49075315 COX6CP2 A/T 0.660 0.96 (0.94–0.97) 1.07E−08 0.96 (0.94–0.97) 3.74E−09 European
region_134 rs34161672 20 56020599 RBM38 A/G 0.321 1.04 (1.02–1.05) 2.40E−06 1.04 (1.03–1.06) 1.64E−07 European
region_142 rs78106213 22 46121230 ATXN10 T/G 0.693 1.04 (1.03–1.06) 2.41E−07 1.05 (1.03–1.06) 8.20E−09 European

All independent association signals presented in this table are those not previously reported.

Chr and Position GRCh37, Alleles risk allele/Reference allele, AF Allele frequency, OR odds ratio, CI confidence interval.

aP value derived from trans-ancestry or ancestry-specific meta-analysis under the fixed-effects inverse variance weighted model.

bP value derived from conditional analysis conditioning on all other independent association signals in each fine-mapping region. “NA”—Only a single association signal was detected in the fine-mapping region in the analysis group.